Please login to the form below

Not currently logged in
Email:
Password:

MethylGene appoints Peggy Mulligan as director

Former chief financial officer at Valeant to join Canada-based biotech

Former chief financial officer of Valeant Pharmaceuticals Peggy Mulligan has joined the board of directors at Canada-based MethylGene.

Charles Grubsztajn, president and CEO of the small molecule drug development company, highlighted Mulligan's experience in finances and auditing as reasons for her appointment.

“We look forward to her guidance as we plan for the future,” he said.

Mulligan had previously been chief financial officer and executive VP at Biovail before its merger with Valeant in September 2010 in which she played a key role, co-leading the merger and subsequent integration between the two companies.

She resigned from Valeant in December 2010, just three months after the merger, to pursue other interests.

Prior to her time at Biovail/Valeant, Mulligan served as executive VP and chief financial officer and treasurer of Linamar Corporation from 2005 to 2007.

Previously, she spent eleven years in various roles at the Bank of Nova Scotia, most recently as executive VP, systems and operations.

In 2003 and 2004 Mulligan was also named one of Canada's Top 100 Most Powerful Women by the Women's Executive Network.

21st March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics